Market Cap 20.88M
Revenue (ttm) 0.00
Net Income (ttm) -37.43M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 3,033,000
Avg Vol 669,556
Day's Range N/A - N/A
Shares Out 22.38M
Stochastic %K 24%
Beta 1.38
Analysts Sell
Price Target $6.00

Company Profile

Citius Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of critical care products. Its LYMPHIR, an FDA-approved product, is a targeted immunotherapy for the treatment of cutaneous T-cell lymphoma. The company's late-stage pipeline includes Mino-Lok, an antibiotic lock solution to treat patients with catheter-related bloodstream infections; Halo-Lido, a corticosteroid-lidocaine topical formulation to provide anti-inflammatory and anesthetic reli...

Industry: Biotechnology
Sector: Healthcare
Phone: 908 967 6677
Address:
11 Commerce Drive, First Floor, Cranford, United States
focafoca99
focafoca99 Apr. 25 at 5:57 AM
$CTXR closed a $5 million registered direct offering priced at-the-market under Nasdaq rules. https://www.rapidticker.com/news/ctxr-citius-pharmaceuticals-announces-closing-of-01a290
0 · Reply
yamihere2
yamihere2 Apr. 24 at 9:14 PM
$CTXR Company has done nothing since 2021 but offerings. Absolute joke of a company, need to cut my losses at $1+ now
0 · Reply
SweStonk
SweStonk Apr. 24 at 8:34 PM
$CTXR and what will make this go up? We kinda know now that Lymphir sales dont cover their expenses. They need to make hell of alot more to be profitable and even more to be able to push ML for the small market that is left for it if any and that is if FDA dont tell them they need another trial. Always funny to see these new pumpers getting stuck and throwing out numbers without anything to back it up. And with time they fade out and forgotten while SP keep going lower and lower as it always have after the paid pumps. Every paid pump have taken this lower than before. Mazur never learn....
1 · Reply
TwongStocks
TwongStocks Apr. 24 at 8:30 PM
$CTXR Citius Pharmaceuticals Announces Closing of Registered Direct Offering of $5 Million Priced At-The-Market Under Nasdaq Rules https://www.prnewswire.com/news-releases/citius-pharmaceuticals-announces-closing-of-registered-direct-offering-of-5-million-priced-at-the-market-under-nasdaq-rules-302753106.html
0 · Reply
chuckyry
chuckyry Apr. 24 at 7:02 PM
$CTXR sold the news. Lets see if we can buy back in before another Lennys pump. 😂😂
0 · Reply
JackCampbell
JackCampbell Apr. 24 at 6:14 PM
$CTXR First target $0.86 then $1+ and mutiples from there!
0 · Reply
yamihere2
yamihere2 Apr. 24 at 4:29 PM
$CTXR Lost so much money here. Company is garbage
0 · Reply
senornobody
senornobody Apr. 24 at 4:13 PM
$CTXR lol silly stock, can't believe people still throwing money away here
0 · Reply
JackCampbell
JackCampbell Apr. 24 at 2:13 PM
$CTXR This raise will bring them to profitability already this year! Huge chance here as lymphir works and will gain remarkable market share!
1 · Reply
Cashflow62
Cashflow62 Apr. 24 at 2:07 PM
$CTXR Got a few in the .69 area. Will ride it back up been awhile.......
0 · Reply
Latest News on CTXR
What's Behind The Drop In Citius Pharmaceuticals?

Apr 24, 2026, 10:47 AM EDT - 1 day ago

What's Behind The Drop In Citius Pharmaceuticals?


Citius Pharmaceuticals Transcript: Investor Update

Aug 13, 2024, 8:30 AM EDT - 1 year ago

Citius Pharmaceuticals Transcript: Investor Update


focafoca99
focafoca99 Apr. 25 at 5:57 AM
$CTXR closed a $5 million registered direct offering priced at-the-market under Nasdaq rules. https://www.rapidticker.com/news/ctxr-citius-pharmaceuticals-announces-closing-of-01a290
0 · Reply
yamihere2
yamihere2 Apr. 24 at 9:14 PM
$CTXR Company has done nothing since 2021 but offerings. Absolute joke of a company, need to cut my losses at $1+ now
0 · Reply
SweStonk
SweStonk Apr. 24 at 8:34 PM
$CTXR and what will make this go up? We kinda know now that Lymphir sales dont cover their expenses. They need to make hell of alot more to be profitable and even more to be able to push ML for the small market that is left for it if any and that is if FDA dont tell them they need another trial. Always funny to see these new pumpers getting stuck and throwing out numbers without anything to back it up. And with time they fade out and forgotten while SP keep going lower and lower as it always have after the paid pumps. Every paid pump have taken this lower than before. Mazur never learn....
1 · Reply
TwongStocks
TwongStocks Apr. 24 at 8:30 PM
$CTXR Citius Pharmaceuticals Announces Closing of Registered Direct Offering of $5 Million Priced At-The-Market Under Nasdaq Rules https://www.prnewswire.com/news-releases/citius-pharmaceuticals-announces-closing-of-registered-direct-offering-of-5-million-priced-at-the-market-under-nasdaq-rules-302753106.html
0 · Reply
chuckyry
chuckyry Apr. 24 at 7:02 PM
$CTXR sold the news. Lets see if we can buy back in before another Lennys pump. 😂😂
0 · Reply
JackCampbell
JackCampbell Apr. 24 at 6:14 PM
$CTXR First target $0.86 then $1+ and mutiples from there!
0 · Reply
yamihere2
yamihere2 Apr. 24 at 4:29 PM
$CTXR Lost so much money here. Company is garbage
0 · Reply
senornobody
senornobody Apr. 24 at 4:13 PM
$CTXR lol silly stock, can't believe people still throwing money away here
0 · Reply
JackCampbell
JackCampbell Apr. 24 at 2:13 PM
$CTXR This raise will bring them to profitability already this year! Huge chance here as lymphir works and will gain remarkable market share!
1 · Reply
Cashflow62
Cashflow62 Apr. 24 at 2:07 PM
$CTXR Got a few in the .69 area. Will ride it back up been awhile.......
0 · Reply
focafoca99
focafoca99 Apr. 24 at 1:52 PM
$CTXR prices a $5 million registered direct offering with concurrent five-year private warrants. https://www.rapidticker.com/news/ctxr-citius-pharmaceuticals-announces-a-registered-4ce9fb
0 · Reply
TwongStocks
TwongStocks Apr. 24 at 1:36 PM
$CTXR Prospectus for the offering, with updated details... https://www.sec.gov/Archives/edgar/data/1506251/000121390026047296/ea0287618-424b5_citius.htm • 4,730,457 Shares at $0.985 • 345,686 pre-funded warrants with an upfront purchase price of $0.9849 and an exercise price of $0.0001. Pre-funded warrants will not expire until they are exercised in full. • 5,076,143 common warrants with a $0.86 exercise price & 355,330 placement agent warrants with a $1.2313 exercise price will be registered in a separate registration statement. • 27,452,570 shares outstanding after offering, assuming full exercise of pre-funded warrants and no exercise of common warrants. • Net proceeds approximately $4.5 million after deducting placement agent fees, commissions, and estimated offering expenses. • CTXR is prohibited from entering into any other offerings for 45 days.
1 · Reply
SweStonk
SweStonk Apr. 24 at 1:29 PM
$CTXR You cant be suprised.... We all know CTOR is Mazurs lifeboat hence why he dont care what happen to CTXRs SP.
0 · Reply
OpenOutcrier
OpenOutcrier Apr. 24 at 12:47 PM
$CTXR (-17.2% pre) Citius Pharmaceuticals raises $5 million in registered direct offering https://ooc.bz/l/99955
1 · Reply
DARKP00L
DARKP00L Apr. 24 at 12:46 PM
$CTXR 08:31 on Apr. 24 2026 Citius Pharmaceuticals Announces a Registered Direct Offering of $5 Million Priced At-The-Market Under Nasdaq Rules #tradeideas
0 · Reply
mlmichel13
mlmichel13 Apr. 24 at 12:43 PM
$CTXR For a guy that has accomplished JACK SHIT in 10 years, other than blowing a couple hundered million dollars. Wonder if his stock awards are in CTOR, since he keeps diluting CTXR and is just using it as a piggy bank at this point. Keep it going a few more years to recover his investment and screw over everyone else.
1 · Reply
InvestorRelations_
InvestorRelations_ Apr. 24 at 12:41 PM
$CTXR lets goo 🤪
0 · Reply
900fix
900fix Apr. 24 at 12:36 PM
$CTXR . That's the Lying Lenny everyone knows. Delay and dilute. It's the only thing he knows. He couldn't run a 7-11.
0 · Reply
bear_foocker
bear_foocker Apr. 24 at 12:34 PM
$CTXR i like i said yesterday everytime. At least Lenny is a predictable pos
0 · Reply
Tadeo17
Tadeo17 Apr. 24 at 12:25 PM
0 · Reply
TwongStocks
TwongStocks Apr. 24 at 12:12 PM
$CTXR Offering today explains yesterday's marketing campaign...
0 · Reply
TwongStocks
TwongStocks Apr. 24 at 12:01 PM
$CTXR Citius Pharmaceuticals Announces a Registered Direct Offering of $5 Million Priced At-The-Market Under Nasdaq Rules https://www.prnewswire.com/news-releases/citius-pharmaceuticals-announces-a-registered-direct-offering-of-5-million-priced-at-the-market-under-nasdaq-rules-302752444.html 5,076,143 shares at $0.985 5,076,143 warrants at $0.86
1 · Reply